• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Reata Pharma (NQ: RETA )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Reata Pharma

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
    According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
    Via Benzinga
    An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8
    Paying Attention To Gold Miners On Zero Hedge on Monday, contributing editor “Quoth The Raven” suggested “paying urgent attention to gold miners”: 
    Via Benzinga
    Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Shareholder Notice: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 10/04/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Reata Pharmaceuticals, Inc. 
    Via SBWire
    Biogen Completes Acquisition of Reata Pharmaceuticals
    From Biogen Inc.
    Via GlobeNewswire
    Analyst Ratings for Reata Pharmaceuticals
    Via Benzinga
    Reata Pharmaceuticals Inc. (NASDAQ: RETA) Climbs to New 52-Week High
    Via Investor Brand Network
    Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.
    From Reata Pharmaceuticals, Inc.
    Via Business Wire
    Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
    Buying a biotech is a good move, but it might not be enough to entice investors. 
    Via The Motley Fool
    7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
    Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
    Via InvestorPlace
    The 7 Most Promising Momentum Stocks to Own Now
    These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility. 
    Via InvestorPlace
    The 3 Most Promising Pharma Stocks to Own Now
    A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride. 
    Via InvestorPlace
    REATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone Energy, Inc. (NYSE - ESTE), Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    With an Acquisition on the Way, Is Biogen Stock a Buy?
    Can the biotech finally get back in the good graces of investors? 
    Via The Motley Fool
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    REATA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
    Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
    Biogen also recently announced a plan to cut costs and focus investment on high-growth areas. 
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
    Via Benzinga
    Could This Stock Be the Next Biotech Buyout?
    A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next. 
    Via The Motley Fool
    Crude Oil Edges Higher; Colgate-Palmolive Posts Upbeat Earnings
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Friday. The Dow traded up 0.42% to 35,432.07 while the NASDAQ rose 1.79% to 14,301.74. The... 
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
    Despite Thursday's downside reversal, the major indexes had a solid advance. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.